Drug-Induced Seizures:A 10-Year Experience
Neurol 34:1582-1586, Messing,R.O.,et al, 1984
Use of Monoclonal Antibody Panel to Identify Malignant Cells in Cerebrospinal Fluid
Lancet 1:1095-1098, Coakham,H.B.,et al, 1984
The Risk of Recurrence of Nonfebrile Seizures in Children
Neurol 34:637-641, Hirtz,D.G.,et al, 1984
Long-Term Follow-up of Absence Seizures
Neurol 33:1590-1595, Sato,S.,et al, 1983
Epileptic Seizure in a Population of 6000
BMJ 287:641-647, Goodridge,D.M.G.,et al, 1983
Pyridoxine Deficiency & Peripheral Neuropathy Associated with Long-Term Phenelzine Therapy
Am J Med 75:887-888, Heller,C.A.,et al, 1983
Outcome in Neonates with Convulsions Treated in an Intensive Care Unit
Ann Neurol 14:642-647, Gergman,I.,et al, 1983
Epilepsies of Infancy & Childhood
Ann Neurol 13:113-124, Gomez,M.R.,et al, 1983
Long-Term Prognosis in Two Forms of Childhood Epilepsy:Absence Seizures & Epilepsy with Rolandic EEG Foci
Ann Neurol 13:642-648, Loiseau,P.,et al, 1983
Psychogenic Seizures:A Clinical Study with Follow-up Data
Neurol 33:498-502, Krumholz,A.,et al, 1983
Aldose Reductase Inhibition Improves Nerve Conduction Velocity In Diabetic Patients
NEJM 308:119-125, Judzewitsch,R.G.,et al, 1983
Acetazolamide-Responsive Episodic Ataxia Syndrome
Neurol 33:1212-1214, Zasorin,N.L.,et al, 1983
Memory Enhancement with Oral Physostigmine in Alzheimer's Disease
NEJM 308:720-721, Thal,L.J.,et al, 1983
Oral Physostigmine & Lecithin Improve Memory in Alzheimer Disease
Ann Neurol 13:491-496, Thal,L.J.,et al, 1983
Chronic Inflammatory Polyradiculoneuropathy Complicated by Factor VIII Antibody
Neurol 33:1224-1226, Berger,J.R.,et al, 1983
Ophthalmoscopy of the Retinal Nerve Fiber Layer
Arch Neurol 39:226-233, Newman,N.M.,et al, 1982
Deprenyl In Parkinson's Disease
Lancet 2:695-696, , 1982
Prognosis In Childhood Epilepsy
NEJM 306:831-836, Thurston,J.H.,et al, 1982
Prognosis Of Childhood Epilepsy-Another Look
NEJM 306:861-862, Berg,B.O., 1982
Seizure Recurrence After A First Unprovoked Seizure
NEJM 307:522-528, Hauser,W.A.,et al, 1982
Epileptic Patients Who are Refractory to Anticonvulsant Medications
Neurol 32:1382-1384, Rodin,E.,et al, 1982
Memory Decline in the Aged:Treatment with Lecithin & Physostigmine
Neurol 32:944-950, Drachman,D.A.,et al, 1982
Central Sleep Apnea, Improvement With Acetazolamide Therapy
Arch Int Med 142:1816-1819, White,D.P.,et al, 1982
Early Prognosis of Epilepsy
BMJ 285:1699-1701, Shorvon,S.D.,et al, 1982
Amitriptyline-induced Ophthalmoplegia
Neurol 31:1188-1190, Spector,R.H.,et al, 1981
Prognosis of Isolated Seizures in Adult Life
BMJ 283:1364-1365, Cleland,P.G.,et al, 1981
Double-blind, Triple-crossover Trial of Low Doses of Oral Physostigmine in Inherited Ataxias
Neurol 31:288-292, Kark,R.A.P.,et al, 1981
Plasma Pyridostigmine Levels in Myasthenia Gravis
Neurol 31:145-150, White,M.C.,et al, 1981
Acute Effects of Acetazolamide in Hyperkalemic Periodic Paralysis
Neurol 31:725-729, Riggs,J.E.,et al, 1981
Deprenyl in Parkinson Disease
Neurol 31:19-23, Eisler,T.,et al, 1981
Long-term Prognosis after Infantile Spasms:Statistical Study of Prognostic Factors
Develop Med Child Neurol 23:51-65, Marsumoto,A.,et al, 1981
Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980
Increased Ratio of Carbidopa to Levodopa in Treatment of Parkinson's Disease
Arch Neurol 37:723-726, Tourtellotte,W.W.,et al, 1980
Sinemet-25/100
Medical Letter, 22:511980., , 1980
Acquired Hemophilia, Meningioma, & Diphenyl-hydantoin Therapy
J Neurosurg 53:600-605, O'Reilly,R.A.,et al, 1980
Physostigmine In Gilles De La Tourettes Syndrome
NEJM 302:298, Stahl,S.M.,et al, 1980
Increased Dosage of Carbidopa in Patients with Parkinson's Disease Receiving Low Doses of Levodopa
Arch Neurol 37:146-149, Hoehn,M.M., 1980
Memory & Cognitive Function in the Elderly, A Preliminary Trial of Physostigmine
Arch Neurol 37:674-675, Drachman,D.A.,et al, 1980
Acetazolamide-Induced Improvement in Hydro-cephalus
Arch Neurol 37:376, Donat,J.F., 1980
Anticholinergic Toxicity
NEJM 300:1278, Caine,E.D., 1979
Physostigmine in Reye Syndrome
Ann Neurol 5:105, Pettegrew,J.W.,et al, 1979
Effects of Physostigmine & Lecithin on Memory in Alzheimer Disease
Ann Neurol 6:219-221, Peters,B.H.,et al, 1979
Enhancement Of Memory By Physostigmine
NEJM 301:946, Davis,K.L.,et al, 1979
Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979
Familial Periodic Ataxia
Arch Neurol 36:568-569, Donat,J.R.,et al, 1979
Effects of Acetazolamide on Myotonia
Ann Neurol 3:531, Griggs,R.C.,et al, 1978
Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978
Amantadine Intoxication Reversed by Physostigmine
NEJM 298:516, Casey,D.E., 1978
Comparative Effectiveness of Two Extracerebral DOPA Decarboxylase Inhibitors in Parkinson Disease
Neurol 28:964-968, Lieberman,A.,et al, 1978
Hereditary Paroxysmal Ataxia:Response to Acetazolamide
Neurol 28:1259-1264, Griggs,R.C.,et al, 1978